Glycemic Response to Oral Nutrition Supplements

N

Nestlé

Status

Completed

Conditions

Diabetes

Treatments

Other: ONS

Study type

Interventional

Funder types

Industry

Identifiers

NCT02612675
13.10.US.HCN

Details and patient eligibility

About

This will be a randomized, cross-over study of two oral nutrition supplements in individuals with Type 2 Diabetes.

Enrollment

13 patients

Sex

All

Ages

20 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 20-75 yrs
  • Type 2 diabetes controlled with diet or diet and oral agent, with the exception of sulfonylureas such as glimepiride (Amaryl), glipizide (Glucotrol/Glucotrol XL) and glyburide (DiaBeta, Micronase, Glynase Prestabs); meglitinides such as reaglinide (Prandin) and nateglinide (Starlix); and alpha-glucosidase inhibitors such as acarbose (Precose) and miglitol (Glyset)
  • Hemoglobin A1C less than 9.0%
  • Fasting blood glucose less than 180 mg

Exclusion criteria

Allergy to milk protein or any other component of the formula

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

13 participants in 2 patient groups

Standard ONS
Active Comparator group
Description:
Nutritional beverage (Oral Nutrition Supplement) designed for oral consumption
Treatment:
Other: ONS
Low Carbohydrate ONS
Experimental group
Description:
Nutritional beverage (Oral Nutrition Supplement) designed for oral consumption
Treatment:
Other: ONS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems